Table 2. Infectious disease status of participants who had blood draw (N = 435–439*).
| n | % | 95%CI | |
|---|---|---|---|
| Tested for HBV (N = 438) | |||
| HBV exposed (anti-HBc positive) | 130 | 29.7 | 25.4–34.2 |
| Chronic HBV infection (HBsAg positive & anti-HBc positive) | 11 | 2.5 | 1.3–4.5 |
| Resolved HBV infection (HBsAg negative & anti-HBc positive) | 119 | 27.2 | 23.1–31.6 |
| Tested for HCV (N = 435) | |||
| HCV exposed (anti-HCV positive) | 10 | 2.3 | 1.1–4.2 |
| Chronic HCV infection (anti-HCV positive & HCV RNA positive) | 3 | 0.7 | 0.1–2.0 |
| Resolved HCV infection (anti-HCV positive & HCV RNA negative) | 7 | 1.6 | 0.7–3.3 |
| Tested for HIV (N = 439) | |||
| HIV infection | 5 | 1.1 | 0.0–2.6 |
| Known HIV infection | 3 | 0.7 | 0.1–2.0 |
| Newly diagnosed HIV infection | 2 | 0.5 | 0.1–1.6 |
Abbreviations: CI–Confidence Interval; HBV–Hepatitis B Virus; HCV–Hepatitis C Virus; HIV–Human Immunodeficiency Virus.
* Participants could refuse testing for any of the three infections. Participants was only offered testing for both HBV and HCV when risk factors were present.